ALBT2 TINA-QUANT ALBUMIN GEN.2 04469658190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-04-28 for ALBT2 TINA-QUANT ALBUMIN GEN.2 04469658190 manufactured by Roche Diagnostics.

Event Text Entries

[74055531] This event occurred in (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[74055533] The customer received questionable results for two samples from the same patient tested for albt2 tina-quant albumin gen. 2 (alb) on a cobas integra 400 plus (i400+) at the customer laboratory and a cobas 6000 c (501) module - c501 at a second laboratory. The first sample from the patient was tested on the customer's i400+ analyzer and resulted as "between 18 and 20" g/l. The patient went to the hospital where the alb on a siemens instrument was 36 g/l. The doctor believed the 36 g/l result was correct, and stated the result from the i400+ analyzer was too low. The first sample was sent to a second laboratory, and the alb was 18 g/l when measured on a c501 analyzer. The roche alb method is an immunoturbidimetric method, whereas the siemens method is a bromocresol method. The difference in results was believed to be related to the difference in methodology. A reagent cassette of the roche bromocresol alb method was sent to the customer for troubleshooting. A second sample from the patient was then tested on the i400+ using both methods on (b)(6) 2017. The result from the immunoturbidimetric method was 20. 8 g/l and the result from the roche bromocresol alb method was 30. 8 g/l. No adverse events were alleged. The serial numbers of the i400+ and c501 analyzers that were used were requested but not provided.
Patient Sequence No: 1, Text Type: D, B5


[79044485] Samples from the patient were provided for investigation. The values obtained by the customer were duplicated. Dilution of the samples did not change the results, so it is unlikely that an interferent to the alb assay is present in the samples.
Patient Sequence No: 1, Text Type: N, H10


[132586186] The bromocresol alb method is less specific than the roche immunoturbidimetric alb method (complained assay), so the bromocresol method can give higher results.
Patient Sequence No: 1, Text Type: N, H10


[132588646] Quality control recovery was of very high quality, precise, and accurate. Gammopathy interference can not be completely excluded, but based on the dilution experiments, no indication for interference was found. The complained alb reagent is highly specific and can therefore give lower results than other methods.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-00913
MDR Report Key6529171
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-04-28
Date of Report2017-09-19
Date of Event2017-04-07
Date Mfgr Received2017-04-07
Date Added to Maude2017-04-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameALBT2 TINA-QUANT ALBUMIN GEN.2
Generic NameALBUMIN, ANTIGEN, ANTISERUM, CONTROL
Product CodeDCF
Date Received2017-04-28
Model NumberNA
Catalog Number04469658190
Lot Number21974301
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-04-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.